Pharmacogenetics and Pharmacogenomics in the Discovery and Development of Medicines

  1. Gregory R. Bock,
  2. Dalia Cohen,
  3. Jamie A. Goode
  1. Allen D. Roses

Published Online: 29 APR 2008

DOI: 10.1002/047084664X.ch9

From Genome to Therapy: Novartis Foundation Symposium 229

From Genome to Therapy: Novartis Foundation Symposium 229

How to Cite

Roses, A. D. (2008) Pharmacogenetics and Pharmacogenomics in the Discovery and Development of Medicines, in From Genome to Therapy: Novartis Foundation Symposium 229 (eds G. R. Bock, D. Cohen and J. A. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/047084664X.ch9

Author Information

  1. GlaxoWellcome Research and Development, Research Triangle Park, NC, USA

Publication History

  1. Published Online: 29 APR 2008
  2. Published Print: 26 SEP 2000

Book Series:

  1. Novartis Foundation Symposia

Book Series Editors:

  1. Novartis Foundation

ISBN Information

Print ISBN: 9780471627449

Online ISBN: 9780470846643

SEARCH

Keywords:

  • pharmacogenetics;
  • pharmacogenomics;
  • susceptibility;
  • gene;
  • genomics;
  • APOE;
  • SNP;
  • single nucleotide polymorphism;
  • disease